This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Maat Pharma. Active years: 2024.
Company Filing History:
Years Active: 2024
Title: Cyrielle Gasc: Innovator in Fecal Microbiota Research
Introduction
Cyrielle Gasc is a notable inventor based in Lyons, France. He has made significant contributions to the field of microbiota research, particularly in the context of treatment-induced inflammation. His innovative work has the potential to impact the medical community and improve patient outcomes.
Latest Patents
Cyrielle Gasc holds 1 patent for his invention titled "Fecal microbiota composition for use in reducing treatment-induced inflammation." This invention relates to the use of fecal microbiota transplant to prevent and/or reduce systemic and gut treatment-induced inflammation in individuals in need.
Career Highlights
Gasc is associated with Maat Pharma, a company focused on developing microbiota-based therapies. His work at Maat Pharma has positioned him as a key player in the advancement of microbiota research and its applications in medicine.
Collaborations
Cyrielle Gasc collaborates with talented professionals such as Emilie Plantamura and Benoît Levast. Their combined expertise contributes to the innovative environment at Maat Pharma.
Conclusion
Cyrielle Gasc's contributions to fecal microbiota research exemplify the importance of innovation in addressing medical challenges. His work not only enhances our understanding of microbiota but also offers promising solutions for treatment-induced inflammation.